ARM'S 2016 ANNUAL REPORT DETAILS INDUSTRY-SPECIFIC STATISTICS COMPILED FROM MORE THAN 730 LEADING CELL THERAPY, GENE THERAPY, TISSUE ENGINEERING AND OTHER REGENERATIVE MEDICINE COMPANIES WORLDWIDE. 

 

REGISTRATION IS OPEN FOR ARM'S 7TH ANNUAL ADVANCED THERAPIES SUMMMIT BEING HELD IN BARCELONA, SPAIN ON MARCH 22, 2O17. THIS MEETING IS A MUTLI-STAKEHOLDER, INTERACTIVE FORUM THAT SEEKS TO ADVANCE THE ATMP SECTOR IN EUROPE. THIS YEAR'S PROGRAM WILL FEATURE IN-DEPTH ROUNDTABLE DISCUSSIONS AND EXTENSIVE NETWORKING OPPORTUNITIES WITH LEADERS IN THE FIELD.

Learn more about ARM's 5th Annual Cell & Gene Therapy Investor Day - April 27, 2017 in Boston! Don't miss the only investor meeting organized specifically for the advanced therapies sector providing unique insight into 30+ top publicly traded and emerging private companies.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more